基质金属蛋白酶-10(MMP-10)加重肾小球肾炎中的足细胞损伤
本研究利用MMP-10敲除小鼠抗肾小球基底膜肾炎模型及GC-A与MMP-10双敲除小鼠,发现MMP-10在肾小球肾炎患者肾脏高表达,MMP-10敲除可减轻白蛋白尿和炎症纤维化基因表达,激活的MMP-10可切割nephrin,提示GC-A缺失上调MMP-10导致nephrin丢失并加重足细胞损伤。
要点
- MMP-10在肾小球肾炎患者肾脏高表达,并与足细胞和内皮细胞共定位。
- MMP-10敲除小鼠在抗GBM肾炎中白蛋白尿及促炎促纤维化mRNA表达低于对照。
- 激活的MMP-10在体外可切割nephrin,参与足细胞损伤。
核心结论
- GC-A缺失导致MMP-10上调,引起nephrin丢失,全身性敲除MMP-10可改善GC-A诱导的足细胞损伤。
研究设计与样本
- 研究使用MMP-10敲除小鼠进行抗肾小球基底膜(GBM)肾炎实验,并构建全身性GC-A与MMP-10双敲除小鼠及足细胞特异性GC-A与全身性MMP-10双敲除小鼠分析肾小球损伤。
- 体外实验检测MMP-10过表达或敲低的小鼠足细胞在肿瘤坏死因子(TNF)-α刺激后炎症mRNA变化。
主要发现
- MMP-10在肾小球肾炎患者肾脏中高表达。
- 在抗GBM肾炎中,MMP-10敲除小鼠较对照小鼠白蛋白尿减少,促炎和促纤维化mRNA表达降低。
- 在ALDO治疗下,全身性或足细胞特异性GC-A与全身性MMP-10敲除小鼠较全身性或足细胞特异性GC-A敲除小鼠白蛋白尿改善、nephrin表达保留、GBM增厚减轻。
- MMP-10与足细胞和内皮细胞共定位。
- 体外实验中,MMP-10过表达上调TNF-α诱导的炎症mRNA变化,而MMP-10敲低减轻炎症;小鼠足细胞与人内皮细胞共培养显示内皮细胞MMP-10降低后炎症减轻;激活的MMP-10在体外可切割nephrin。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Podocytes are integral to maintaining glomerular filtration barrier. Our previous research underscored the crucial role of podocyte guanylyl cyclase-A (GC-A) in the pathogenesis of severe albuminuria in both systemic and podocyte-specific GC-A knockout mice subjected to heminephrectomy, high salt, and aldosterone (ALDO) treatment. This study investigates the role of matrix metalloproteinase-10 (MMP-10) on glomerular injury, which was found to be highly expressed in glomeruli of ALDO-treated GC-A knockout mice. METHODS: To investigate the role of MMP-10 in glomerulonephritis, we used MMP-10 knockout mice subjected to anti-glomerular basement membrane (GBM) nephritis. Additionally, we created systemic GC-A and MMP-10 double knockout mice, as well as podocyte-specific GC-A and systemic MMP-10 double knockout mice, to analyze glomerular injury. In vitro, changes in inflammatory mRNA are examined in MMP-10-overexpressing or -knockdown mouse podocytes following stimulation of tumor necrosis factor (TNF)-α. RESULTS: We demonstrate that MMP-10 is highly expressed in the kidneys of patients with glomerulonephritis. MMP-10 knockout mice showed less albuminuria and lower expression of pro-inflammatory and pro-fibrotic mRNAs compared to control mice in anti-GBM nephritis. Additionally, systemic or podocyte-specific GC-A and systemic MMP-10 knockout mice exhibited improved albuminuria, preserved nephrin expression, and reduced GBM thickening compared to systemic or podocyte-specific GC-A knockout mice with ALDO treatment. MMP-10 was co-localized with podocytes and endothelial cells. In vitro studies using mouse podocytes revealed that MMP-10 overexpression upregulated inflammatory mRNA changes induced by TNF-α, whereas MMP-10 knockdown mitigated inflammation. Co-culture of mouse podocytes with human endothelial cells showed reduced inflammation following MMP-10 reduction in endothelial cells. Moreover, activated MMP-10 cleaved nephrin in vitro, contributing to podocyte injury. CONCLUSION: These findings suggest that GC-A ablation leads to upregulation of MMP-10, resulting in nephrin loss, and that systemic deletion of MMP-10 ameliorates GC-A-induced podocyte injury.
引用
- Ishimura T, Osaki K, Sugioka S, et al. Matrix metalloproteinase (MMP)-10 aggravates podocyte injury in glomerulonephritis. Nephrol Dial Transplant. 2025. PMID: 40328459. doi:10.1093/ndt/gfaf076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。